s6y
Company name or ticker
Search
Veraxa Biotech AG - Post de-SPAC
4
Antz Christoph Rudiger: Statement of changes in beneficial ownership of securities
Filed
Monday, August 31, 2026
Period
Aug 27, 2026
Accession number
0001829126-26-009543
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header